H Sayahi, O Zimhony, WR Jacobs… - Bioorganic & Medicinal …, 2011 - Elsevier Pyrazinamide (PZA), an essential component of short-course anti-tuberculosis chemotherapy, was shown by Saturation Transfer Difference (STD) NMR methods to act as a competitive inhibitor of NADPH binding to purified Mycobacterium tuberculosis fatty acid ...
H McIlleron, M Willemse, HS Schaaf… - The Pediatric …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > Current ... Related articles - All 6 versions
Z Ahmad, MM Fraig, GP Bisson… - Antimicrobial Agents …, 2011 - Am Soc Microbiol Recent in vitro pharmacokinetic data suggest that the currently recommended dose of pyrazinamide may be suboptimal for killing intracellular bacilli in humans. We evaluated a range of pyrazinamide doses against intracellular and extracellular Mycobacterium tuberculosis in chronically ... Cited by 1 - Related articles - All 3 versions
[PDF] from sphinxsai.comGP Chenna, SK Shetty, JB Pai, B Gopinath… - Development, 2011 - sphinxsai.com International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol. 3, No.2, pp 737-741, April-June 2011 ... Ganga Prasad Chenna*, Sathish Kumar Shetty**, Jyoti B.Pai, Gopinath B, Manzoor Ahmed ... Department of Pharmaceutical ... Related articles - View as HTML
S Shang, CA Shanley, ML Caraway… - Antimicrobial agents …, 2011 - Am Soc Microbiol The experimental compound TMC207 is showing promise against infections caused by Mycobacterium tuberculosis both in a variety of animal studies and in the field. In this study, we used the guinea pig model, a species that shows several similarities to human tuberculosis, including the ... Cited by 4 - Related articles - All 4 versions